Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 2)
Brain Neoplasms (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Small Cell (Phase 1/Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 3)
Melanoma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neuroblastoma (Phase 1)
Neuroendocrine Tumors (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Sarcoma (Phase 1)
Skin Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue